---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-102498"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:53:29.299178+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Humacyte enters $50M equity purchase agreement with Lincoln Park Capital

## Summary
- Company can sell up to $50M of common stock to Lincoln Park over 24 months at its discretion.
- Purchase price is 97% of the lower of the daily low or average of three lowest closing prices over prior 10 days.
- Shares not sold below $1.00 floor price; maximum regular purchase of 100,000 shares or $1.5M per day.
- Commitment fee of 115,705 shares issued to Lincoln Park; net proceeds for R&D, commercial launch, and working capital.
- Lincoln Park agrees not to engage in short-selling or hedging during the term.

## SEC filing metadata
- accession: 0001104659-24-102498
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465924102498/0001104659-24-102498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465924102498/tm2424623d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-102498
- JSON: https://secwatch.observer/filing/0001104659-24-102498.json
- Plain text: https://secwatch.observer/filing/0001104659-24-102498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.